This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB06985/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB06985/identifier/pubchem-compound/
n4http://bio2rdf.org/drugbank:
n10http://linked.opendata.cz/resource/drugbank/drug/DB06985/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB06985/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB06985
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB06985 n13:DB06985
dcterms:title
2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
adms:identifier
n9:DB06985 n10:99443456 n11:2T1 n12:25138295
n5:IUPAC-Name
n6:271B6547-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B654D-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B654C-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B6549-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B654A-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B654B-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B6545-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B6546-363D-11E5-9242-09173F13E4C5 n6:271B6543-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6544-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6553-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6554-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B654E-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B654F-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6551-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6550-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6552-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B6559-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B655B-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B655C-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B6558-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B6557-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B655A-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B6548-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B6555-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B6556-363D-11E5-9242-09173F13E4C5